
Roxithromycin 150 mg b.i.d. versus amoxycillin 500 mg/clavulanic acid 125 mg t.i.d. for the treatment of lower respiratory tract infections in general practice
N. C. Karalus, J. E. Garrett, S. D. R. Lang, R. A. Leng, G. N. Kostalas, R. T. M. Cursons, B. C. Cooper, C. J. RyanVolume:
23
Année:
1995
Langue:
english
Pages:
1
DOI:
10.1007/bf02464954
Fichier:
PDF, 1024 KB
english, 1995